Citation: | Chen Wei, Hu Zhiliang, Yi Changhua, Chi Yun, Xiong Qingfang, Tan Chee Wah, Yi Yongxiang, Wang Lin-Fa. An unusual COVID-19 case with over four months of viral shedding in the presence of low neutralizing antibodies: a case report[J]. The Journal of Biomedical Research, 2020, 34(6): 470-474. doi: 10.7555/JBR.34.20200099 |
[1] |
National Health Commission, National Administration of Traditional Chinese Medicine. Diagnosis and treatment protocol for novel coronavirus pneumonia (Trial Version 7)[J]. Chin Med J, 2020, 133(9): 1087–1095. doi: 10.1097/CM9.0000000000000819
|
[2] |
Lu RJ, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding[J]. Lancet, 2020, 395(10224): 565–574. doi: 10.1016/S0140-6736(20)30251-8
|
[3] |
Tan CW, Chia WN, Qin X, et al. A SARS-CoV-2 surrogate virus neutralization test (sVNT) based on antibody-mediated blockage of ACE2-spike (RBD) protein-protein interaction[J]. Nat Biotechnol, 2020, 38(9): 1073–1078. doi: 10.1038/s41587-020-0631-z
|
[4] |
He X, Lau EHY, Wu P, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19[J]. Nat Med, 2020, 26(5): 672–675. doi: 10.1038/s41591-020-0869-5
|
[5] |
Qi L, Yang Y, Jiang DX, et al. Factors associated with the duration of viral shedding in adults with COVID-19 outside of Wuhan, China: a retrospective cohort study[J]. Int J Infect Dis, 2020, 96: 531–537. doi: 10.1016/j.ijid.2020.05.045
|
[6] |
Wölfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019[J]. Nature, 2020, 581(7809): 465–469. doi: 10.1038/s41586-020-2196-x
|
[7] |
Zhou F, Yu T, Du RH, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study[J]. Lancet, 2020, 395(10229): 1054–1062. doi: 10.1016/S0140-6736(20)30566-3
|
[8] |
Liu WD, Chang SY, Wang JT, et al. Prolonged virus shedding even after seroconversion in a patient with COVID-19[J]. J Infect, 2020, 81(2): 318–356. doi: 10.1016/j.jinf.2020.03.063
|
[9] |
Gasparyan AY, Misra DP, Yessirkepov M, et al. Perspectives of immune therapy in coronavirus disease 2019[J]. J Korean Med Sci, 2020, 35(18): e176. doi: 10.3346/jkms.2020.35.e176
|
[10] |
Shen CG, Wang ZQ, Zhao F, et al. Treatment of 5 Critically Ill patients with COVID-19 with convalescent plasma[J]. JAMA, 2020, 323(16): 1582–1589. doi: 10.1001/jama.2020.4783
|